BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Leukemia
NCI Information
Clinical Trials
Leukemia Trials
Bone Marrow Transplant (BMT) Trials
Support Groups
Effects of Treatment
Patient Stories
Leukemia Podcasts and Videos
Bone Marrow and Stem Cell Transplantation
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
201108378
Principal Investigator:
Pusic, Iskra
Title:
Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome
Phase:
I
Disease Site:
Multiple Sites
Participating Site(s):
Main Campus
Map and Directions
South County
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The goal of this study is to determine the best dose of decitabine given after a transplant as maintenance therapy.
We will also evaluate how effective decitabine is in getting rid of remaining disease and providing disease control, by allowing the graft (donor T-cells) to attack and control the growth of remaining cancer cells.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)